ArticleCancers2019

Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs.

Tomomi Sanomachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.